Literature DB >> 24210467

Risk factors for multidrug-resistant bacteremia in hospitalized cancer patients with febrile neutropenia: a cohort study.

Regis G Rosa1, Luciano Z Goldani1, Rodrigo P dos Santos2.   

Abstract

We conducted a prospective cohort study in a single tertiary hospital with the aim of assessing predictors of multidrug-resistant bacteremia in 307 cases of febrile neutropenia in adult patients with cancer. On multivariate analysis using stepwise logistic regression, age (P = .009), duration of neutropenia (P = .022), and presence of an indwelling central venous catheter (P = .022) were associated with bloodstream infection by multidrug-resistant bacteria.
Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Bacterial; Drug resistance; Fever; Immunocompromised host

Mesh：

Year:  2013        PMID： 24210467     DOI： 10.1016/j.ajic.2013.06.025

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


  12 in total

1.  Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.

Authors:  Katsuhiro Miura; Masaru Nakagawa; Hiromichi Takahashi; Yoshihito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Masashi Sakagami; Shimon Ohtake; Sumiko Kobayashi; Atsuko Hojo; Daisuke Kurita; Yujin Kobayashi; Machiko Kusuda; Yukio Hirabayashi; Yoshihiro Hatta; Masami Takei
Journal:  Int J Hematol       Date:  2015-12-29       Impact factor: 2.490

2.  Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia.

Authors:  Beejal R Ganti; Bernard L Marini; Jerod Nagel; Dale Bixby; Anthony J Perissinotti
Journal:  Support Care Cancer       Date:  2016-10-14       Impact factor: 3.603

3.  Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy.

Authors:  Andreas F Widmer; Winfried V Kern; Jan A Roth; Markus Dettenkofer; Tim Goetting; Hartmut Bertz; Christian Theilacker
Journal:  Infection       Date:  2019-06-11       Impact factor: 3.553

4.  Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience.

Authors:  D Averbuch; C Avaky; M Harit; P Stepensky; I Fried; T Ben-Ami; V Temper; Y Peled; H Troen; R Masarwa; W Abu Ahmad; M Weintraub; S Revel-Vilk; D Engelhard
Journal:  Infection       Date:  2017-02-15       Impact factor: 3.553

5.  Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.

Authors:  Jessica R Galloway-Peña; Yushu Shi; Christine B Peterson; Pranoti Sahasrabhojane; Vancheswaran Gopalakrishnan; Chelcy E Brumlow; Naval G Daver; Mansour Alfayez; Prajwal C Boddu; Md Abdul Wadud Khan; Jennifer A Wargo; Kim-Anh Do; Robert R Jenq; Dimitrios P Kontoyiannis; Samuel A Shelburne
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

6.  Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.

Authors:  Bernard L Marini; Shannon M Hough; Kevin S Gregg; Haya Abu-Seir; Jerod L Nagel
Journal:  Support Care Cancer       Date:  2015-01-10       Impact factor: 3.603

7.  Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia.

Authors:  Youn-Jung Kim; Sung Min Jung; Jihoon Kang; Seung Mok Ryoo; Chang Hwan Sohn; Dong-Woo Seo; Kyoung Soo Lim; Jin Won Huh; Sung-Han Kim; Won Young Kim
Journal:  Intern Emerg Med       Date:  2019-01-01       Impact factor: 3.397

8.  Bloodstream infections in patients with hematological malignancies: which is more fatal - cancer or resistant pathogens?

Authors:  Habip Gedik; Funda Simşek; Arzu Kantürk; Taner Yildirmak; Deniz Arica; Demet Aydin; Naciye Demirel; Osman Yokuş
Journal:  Ther Clin Risk Manag       Date:  2014-09-17       Impact factor: 2.423

9.  Prevalence of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Causing Bloodstream Infections in Cancer Patients from Southwest of Iran.

Authors:  Effat Abbasi Montazeri; Azar Dokht Khosravi; Morteza Saki; Mehrandokht Sirous; Bijan Keikhaei; Sakineh Seyed-Mohammadi
Journal:  Infect Drug Resist       Date:  2020-05-06       Impact factor: 4.003

10.  Prospective Evaluation of Infection Episodes in Cancer Patients in a Tertiary Care Academic Center: Microbiological Features and Risk Factors for Mortality.

Authors:  Nursel Çalık Başaran; Ergun Karaağaoğlu; Gülşen Hasçelik; Mine Durusu Tanrıöver; Murat Akova
Journal:  Turk J Haematol       Date:  2016-04-18       Impact factor: 1.831
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.